Pharmafile Logo
Pharmafocus logo
Advanced Search

Drug pricing

Showing 15 posts of 65 posts found.

PM David Cameron

ABPI hits back at Prime Minister’s criticism of high drug prices

October 15, 2015
Sales and Marketing ABPI, Drug pricing, Duchenne Muscular Dystrophy, NICE, Translarna, ataluren, david cameron, prime minister, rare disease

The ABPI has responded to comments made by UK Prime Minister David Cameron during yesterday’s Prime Minster’s Questions, in which …

News
Hilary Clinton

Hilary Clinton’s pharma ‘enemies’ amongst her biggest financial supporters

October 14, 2015
Drug pricing, Hilary Clinton, US, pricing reform

Hilary Clinton’s plans to make waging war with pharma companies a central plank of her US presidential campaign have been …

News
Soliris

Alexion to challenge Canadian price of Soliris in court

September 28, 2015
Sales and Marketing Alexion, Canada, Drug pricing, Patented Medicine Prices Review Board, eculizumab, soliris

Alexion Pharmaceuticals is taking the Canadian government to court for its attempt to lower the price of the rare disease …

News
Health secretary Jeremy Hunt

Price tags on medicine packs a “headline grabbing gimmick”

August 7, 2015
Manufacturing and Production, Medical Communications Drug pricing, Jeremy Hunt, NHS, adherence, compliance

Plans to include a price tag on prescription medicines in England worth more than £20 have been dismissed as a …

News

Pfizer and Flynn rapped for overcharging on anti-epilepsy drug

August 6, 2015
Manufacturing and Production, Sales and Marketing CMA, Drug pricing, Flynn Pharma, Pfizer, competitions markets authority, epilepsy, generics, phenytoin, pricing

Pharma firms Pfizer and Flynn Pharma have been accused by the UK’s competition watchdog of charging ‘excessive and unfair’ prices …

News

Novo Nordisk pulls Tresiba in Germany after pricing row

July 6, 2015
Manufacturing and Production, Sales and Marketing Drug pricing, Germany, Novo Nordisk, Reimbursement, Tresiba, market access

Novo Nordisk has discontinued its distribution of once-daily basal insulin Tresiba after pricing talks with the German body that represents …

News
china_flag

Chinese government to lift drug price controls

May 5, 2015
Sales and Marketing China, Drug pricing, GSK, IMS, Xarelto, government

The Chinese government has announced that it will remove price caps for most medicines and allow the market to play …

News
pillsphotos1

The Pharmafocus debate: Is the price of new hepatitis C treatments fair?

April 27, 2015
Research and Development, Sales and Marketing Doctors of the World, Drug pricing, EFPIA, Gilead, MSF, drug cost, hepatitis C, patents, sofosbuvir, sovaldi

YES – says Richard Bergström, director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA), who argues that …

Feature
Statins image

Researchers question ‘bias’ NICE on statins

June 11, 2014
Sales and Marketing Drug pricing, Haslam, NHS, NICE, statins

Doctors are warning that NICE’s desire to increase prescriptions of statins in England is based on pharma-funded research that ignores …

News
Channel 4 image

NHS documentary counts cost

April 25, 2014
Medical Communications, Sales and Marketing Channel 4, Drug pricing, NHS, PPRS, vba

The funding issues facing the NHS are to be explored in a new documentary series on Channel 4. Set to …

News
Andrew Lansley

New UK drug pricing plans ‘delayed’

October 7, 2013
Medical Communications, Sales and Marketing Drug pricing, Hunt, Lansley, NHS, NICE, VBP

News
Sanofi HQ

Sanofi ‘co-operating’ with China bribery case

August 12, 2013
Medical Communications, Sales and Marketing China, Drug pricing, GSK, Sanofi, bribery

News
ABPI image

ABPI ‘fears for future of UK research’ ahead of pricing talks

June 7, 2012
Sales and Marketing ABPI, Drug pricing, PPRS, Stephen Whitehead, VBP

The UK pharmaceutical industry says too great a focus on ‘breakthrough’ drugs could undermine the future of medical research in …

News
Boehringer-Lilly's Trajenta

Boehringer-Lilly won’t launch Trajenta in Germany

September 5, 2011
Sales and Marketing Drug pricing, Germany, Tradjenta, Trajenta, price cuts

Boehringer Ingelheim and Lilly have decided not to launch their new diabetes drug Trajenta in Germany and say the country’s …

News

Philippines pricing controls: Pfizer ‘considered taking drugs off the market’

September 2, 2011
Sales and Marketing Drug pricing, Philippines, price cuts

Pfizer considered withdrawing some of its products from the Philippines rather than face planned pricing controls, according to a US …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026